MLchartDataset catalogue

Angiocept

Term · Oncology and biomedicine · MLC-T-ONC-000535

A substance being studied in the treatment of cancer. Angiocept may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells. It is a type of vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor and a type of antiangiogenesis agent. Also called CT-322 and VEGFR-2 inhibitor CT-322.

Table 1. Record
IdentifierMLC-T-ONC-000535
FieldOncology and biomedicine
SynonymsCT-322; VEGFR-2 inhibitor CT-322
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-000535",
  "term": "Angiocept",
  "field": "Oncology and biomedicine",
  "definition": "A substance being studied in the treatment of cancer. Angiocept may prevent the growth of new blood vessels that tumors need to grow and may kill cancer cells. It is a type of vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor and a type of antiangiogenesis agent. Also called CT-322 and VEGFR-2 inhibitor CT-322.",
  "synonyms": [
    "CT-322",
    "VEGFR-2 inhibitor CT-322"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/angiocept/"
}

Record 1,112 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.